Lee Kevin's Form 4 filing
Bicycle Therapeutics PLC (BCYC) · filed Jan 6, 2025
- Accession no.
- 0001415889-25-000921
- Filed
- Jan 6, 2025
- Trade date
- Jan 2-3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $173.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lee KevinCIK 0001776938 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Ordinary Shares | AGrant or awardAcquired | +123,200 | $0.00 | $0 | 504,064 | Direct | |
| Jan 2, 2025 | Ordinary Shares | SSaleDisposed | −9,038 | $14.09 | −$127,345.42 | 495,026 | Direct | |
| Jan 3, 2025 | Ordinary Shares | SSaleDisposed | −3,092 | $14.75 | −$45,607 | 491,934 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Ordinary Shares | AGrant or awardAcquired | +308,000 | $0.00 | $0 | 308,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.